Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"Telaprevir"”.

  1. Drug resistance mechanisms and drug design strategies for human immunodeficiency virus and hepatitis c virus proteases

    … focuses on an HCV NS3/4A protease inhibitor, telaprevir, which is approved for the treatment of patients infected with the HCV genotype 1. The enzyme assays and molecular dynamic studies suggest that telaprevir may retain sufficient potency to treat the non-genotype 1 HCV strains.</p>

    wayne-thes Repository record for Drug resistance mechanisms and drug design strategies for human immunodeficiency virus and hepatitis c virus proteases (opens in a new tab)

  2. Frequência de anemia em paciente tratados da hepatite C com terapia tripa num ambulatório referência em hepatologia de Salvador (Bahia - Brasil)

    … e 33,3% cirróticos. O inibidor de protease Telaprevir foi utilizado em 85,7% dos pacientes e o Boceprevir em 14,3%. A média de Hemoglobina dos pacientes foi analisada ao longo das semanas e estes tiveram uma maior queda na semana 12. Discussão – A maioria dos pacientes começaram o tratamento …

    brazil-ufba Repository record for Frequência de anemia em paciente tratados da hepatite C com terapia tripa num ambulatório referência em hepatologia de Salvador (Bahia - Brasil) (opens in a new tab)

  3. A Decade of Hepatitis C at the UCT/GSH Liver Clinic in the Pre-DAA era

    … the first generation add-on protease inhibitor, telaprevir, were included. Results 238 patients were included in the analysis, median age of 47 (IQR 37-58) years, men 60.5%. Men were significantly younger than women, 43.5 (35-52) vs 55 (42-64) years, respectively, p< 0.0001. Ethnically, the …

    cape-town Repository record for A Decade of Hepatitis C at the UCT/GSH Liver Clinic in the Pre-DAA era (opens in a new tab)